Agilent Technologies (NYSE:A – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided EPS guidance of $5.06-$5.08 for the period, compared to the consensus EPS estimate of $4.76. The company issued revenue guidance of $6.75 billion-$6.78 billion, compared to the consensus revenue estimate of $6.51 billion. Agilent Technologies also updated its Q4 2022 guidance to $1.38-$1.40 EPS.
Agilent Technologies Stock Performance
NYSE:A traded down $2.00 during midday trading on Friday, hitting $122.39. The company’s stock had a trading volume of 30,153 shares, compared to its average volume of 1,427,989. Agilent Technologies has a fifty-two week low of $112.52 and a fifty-two week high of $174.35. The firm’s 50 day moving average is $130.58 and its 200-day moving average is $126.98. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.94 and a quick ratio of 1.41. The firm has a market cap of $36.23 billion, a P/E ratio of 28.33, a P/E/G ratio of 2.49 and a beta of 1.06.
Agilent Technologies (NYSE:A – Get Rating) last issued its quarterly earnings results on Tuesday, August 16th. The medical research company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.14. Agilent Technologies had a net margin of 19.94% and a return on equity of 28.46%. The company had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the company earned $1.10 EPS. Agilent Technologies’s quarterly revenue was up 8.3% on a year-over-year basis. Equities analysts anticipate that Agilent Technologies will post 5.07 earnings per share for the current fiscal year.
Agilent Technologies Announces Dividend
Analyst Ratings Changes
A number of brokerages have recently commented on A. Evercore ISI raised their price objective on shares of Agilent Technologies to $145.00 in a research note on Monday, August 22nd. StockNews.com raised shares of Agilent Technologies from a buy rating to a strong-buy rating in a research note on Friday, August 26th. KeyCorp dropped their price objective on shares of Agilent Technologies from $195.00 to $155.00 and set an overweight rating on the stock in a research note on Thursday, June 2nd. Credit Suisse Group began coverage on Agilent Technologies in a research report on Wednesday, August 24th. They set an outperform rating and a $165.00 target price on the stock. Finally, Robert W. Baird increased their target price on Agilent Technologies from $155.00 to $160.00 and gave the company an outperform rating in a research report on Wednesday, August 17th. Four investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus price target of $151.31.
Insider Buying and Selling at Agilent Technologies
In other news, VP Padraig Mcdonnell sold 2,506 shares of Agilent Technologies stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $134.33, for a total transaction of $336,630.98. Following the transaction, the vice president now owns 15,320 shares in the company, valued at approximately $2,057,935.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of A. Synovus Financial Corp raised its holdings in shares of Agilent Technologies by 2.3% during the 1st quarter. Synovus Financial Corp now owns 6,751 shares of the medical research company’s stock worth $895,000 after acquiring an additional 153 shares during the period. Blair William & Co. IL increased its position in shares of Agilent Technologies by 7.3% during the 1st quarter. Blair William & Co. IL now owns 28,606 shares of the medical research company’s stock worth $3,785,000 after purchasing an additional 1,957 shares during the last quarter. Sequoia Financial Advisors LLC increased its position in shares of Agilent Technologies by 52.1% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the medical research company’s stock worth $309,000 after purchasing an additional 799 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Agilent Technologies by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company’s stock worth $3,246,209,000 after purchasing an additional 261,435 shares during the last quarter. Finally, Zions Bancorporation N.A. increased its position in shares of Agilent Technologies by 10.8% during the 1st quarter. Zions Bancorporation N.A. now owns 2,880 shares of the medical research company’s stock worth $381,000 after purchasing an additional 281 shares during the last quarter.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Why Does Tesla Stock Remain Resilient?
- Is Costco’s Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.